Fully agree. This line of thinking relate to amrn current inactive promotion. How long are they planing to do this? Until appeal, that is initial thought I guess. What if the outcome is unclear because of remanding to dc or anything else, are they going to defer promotion forever? In that case, they may as well just say bye to us market.
BO is ultimate solution. I just don’t see any benefits waiting it longer, except mgmt can’t milk any longer.
All sound statements but the exit door for settlement I fear has closed. There is no pathway to settlement by vacatur that can seal the entry of other generic challengers with certainty. Hikma/Reddys have hit a lucky break with a potty Judge Du-zy, and they will ride the play for all they can. no amount of logic about wasted building of market by Amrn for them etc will hold water. It is in their nature and they will follow suit. Of course if Amrn could find a buyer BP we know that under current uncertainties the shareholders would be cheated in acquisition price. The more I see of our lot as shareholders, the more I feel Singer is now at the lead of our Charge of the Light Brigade: "Ours not to reason why.."
Was there a man dismay’d? Not tho’ the soldier knew Some one had blunder’d: Theirs not to make reply, Theirs not to reason why, Theirs but to do and die: Into the valley of Death Rode the six hundred. Alfred Lord Tennyson
PS Want some more good news? read this from the investorvillage board: ++Hikma Pharmaceuticals (LSE: HIK) today announced an exclusive license, supply and distribution agreement between its wholly-owned subsidiary Hikma Pharmaceuticals International and Beijing Sciecure Pharmaceutical, a leading Chinese company that researches, develops and manufactures high-quality pharmaceutical products for global markets++
Marjac..I think AMRN is in better hands with BP ( I don't own AMRN for a buyout ) or with competent management...a buyout would depend on a BP risk appetite for buying AMRN at a price that values the USA assets discounted in all likelihood more than JT/AMRN are welling to accommodate...if AMRN and BP could not agree on a price when there was less uncertainty and the litigation could have been in BP's hands I think it unlikely now. At this point I would love to move on..I agree with you it is far from certainty we will be guided by current management in a responsible and profitable manner after we win appeal...the tragedy here is the wasting of such a fine product to the consumer and potential for shareholders...EU is a whole new subject...AMRN should seriously consider selling EU and rest of world and keeping US untill after win. JT comments on EU gia are paramount to him being to greedy. We are going 3 steps back and 1 step forward and the cliff behind us in in clear view.